147 related articles for article (PubMed ID: 1385399)
1. N-glycosylation is required for human CD2 immunoadhesion functions.
Recny MA; Luther MA; Knoppers MH; Neidhardt EA; Khandekar SS; Concino MF; Schimke PA; Francis MA; Moebius U; Reinhold BB
J Biol Chem; 1992 Nov; 267(31):22428-34. PubMed ID: 1385399
[TBL] [Abstract][Full Text] [Related]
2. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
van der Merwe PA; Barclay AN; Mason DW; Davies EA; Morgan BP; Tone M; Krishnam AK; Ianelli C; Davis SJ
Biochemistry; 1994 Aug; 33(33):10149-60. PubMed ID: 7520278
[TBL] [Abstract][Full Text] [Related]
3. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2.
Withka JM; Wyss DF; Wagner G; Arulanandam AR; Reinherz EL; Recny MA
Structure; 1993 Sep; 1(1):69-81. PubMed ID: 7915183
[TBL] [Abstract][Full Text] [Related]
4. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
Somoza C; Driscoll PC; Cyster JG; Williams AF
J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
[TBL] [Abstract][Full Text] [Related]
6. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.
Arulanandam AR; Withka JM; Wyss DF; Wagner G; Kister A; Pallai P; Recny MA; Reinherz EL
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11613-7. PubMed ID: 7505442
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of the CD2 immunoadhesion domain. Evidence for inclusion of CD2 in an alpha-beta protein folding class.
Recny MA; Neidhardt EA; Sayre PH; Ciardelli TL; Reinherz EL
J Biol Chem; 1990 May; 265(15):8542-9. PubMed ID: 1971273
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
[TBL] [Abstract][Full Text] [Related]
9. 1H resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2.
Wyss DF; Withka JM; Knoppers MH; Sterne KA; Recny MA; Wagner G
Biochemistry; 1993 Oct; 32(41):10995-1006. PubMed ID: 8105887
[TBL] [Abstract][Full Text] [Related]
10. Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48.
van der Merwe PA; Brown MH; Davis SJ; Barclay AN
EMBO J; 1993 Dec; 12(13):4945-54. PubMed ID: 7903240
[TBL] [Abstract][Full Text] [Related]
11. Detection of a glycosylation-dependent ligand for the T lymphocyte cell adhesion molecule CD2 using a novel multimeric recombinant CD2-binding assay.
Parish CR; Recny MA; Knoppers MH; Waldron JC; Warren HS
J Immunol; 1993 Jun; 150(11):4833-43. PubMed ID: 7684413
[TBL] [Abstract][Full Text] [Related]
12. The NH2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2.
van der Merwe PA; McPherson DC; Brown MH; Barclay AN; Cyster JG; Williams AF; Davis SJ
Eur J Immunol; 1993 Jun; 23(6):1373-7. PubMed ID: 8099016
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58.
Hahn WC; Burakoff SJ; Bierer BE
J Immunol; 1993 Apr; 150(7):2607-19. PubMed ID: 7681075
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
Osborn L; Day ES; Miller GT; Karpusas M; Tizard R; Meuer SC; Hochman PS
J Exp Med; 1995 Jan; 181(1):429-34. PubMed ID: 7528777
[TBL] [Abstract][Full Text] [Related]
15. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway.
Albert-Wolf M; Meuer SC; Wallich R
Int Immunol; 1991 Dec; 3(12):1335-47. PubMed ID: 1723296
[TBL] [Abstract][Full Text] [Related]
16. CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.
Menu E; Tsai BC; Bothwell AL; Sims PJ; Bierer BE
J Immunol; 1994 Sep; 153(6):2444-56. PubMed ID: 7521361
[TBL] [Abstract][Full Text] [Related]
17. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59.
Hahn WC; Menu E; Bothwell AL; Sims PJ; Bierer BE
Science; 1992 Jun; 256(5065):1805-7. PubMed ID: 1377404
[TBL] [Abstract][Full Text] [Related]
18. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.
Kato K; Koyanagi M; Okada H; Takanashi T; Wong YW; Williams AF; Okumura K; Yagita H
J Exp Med; 1992 Nov; 176(5):1241-9. PubMed ID: 1383383
[TBL] [Abstract][Full Text] [Related]
19. Conformation and function of the N-linked glycan in the adhesion domain of human CD2.
Wyss DF; Choi JS; Li J; Knoppers MH; Willis KJ; Arulanandam AR; Smolyar A; Reinherz EL; Wagner G
Science; 1995 Sep; 269(5228):1273-8. PubMed ID: 7544493
[TBL] [Abstract][Full Text] [Related]
20. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2.
Chan PY; Lawrence MB; Dustin ML; Ferguson LM; Golan DE; Springer TA
J Cell Biol; 1991 Oct; 115(1):245-55. PubMed ID: 1717480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
